levonorgestrel has been researched along with cyproterone in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 5 (27.78) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Christiansen, C; Marslew, U; Overgaard, K; Riis, BJ | 1 |
| Christiansen, C; Haarbo, J; Hassager, C; Jensen, SB; Riis, BJ | 1 |
| Christiansen, C; Marslew, U; Riis, B | 1 |
| Hümpel, M; Li, QG | 1 |
| Jung-Hoffman, C; Kuhl, H | 1 |
| Haspels, AA; Kloosterboer, HJ; van der Berg, H; van der Vange, N | 1 |
| Huber, J; Spona, J | 1 |
| Kuhl, H; Mehlis, W; Sandow, J; Taubert, HD; Weber, W | 1 |
| Cersosimo, L; Consalvo, F; Iannucci, D; Orgiu, G | 1 |
| Düsterberg, B | 1 |
| Düsterberg, B; Hümpel, M; Speck, U | 1 |
| Jick, H; Vasilakis-Scaramozza, C | 1 |
| Basta, A; Gregoraszczuk, EL; Kolodziejczyk, J; Krzysiek, J; Kurek, S; Milewicz, T; Stachura, J; Sztefko, K | 1 |
| Rajalakshmi, M | 1 |
| Voelker, R | 1 |
| de Bastos, M; Dekkers, OM; Helmerhorst, FM; Rosendaal, FR; Stegeman, BH; Stijnen, T; Van Hylckama Vlieg, A | 1 |
2 review(s) available for levonorgestrel and cyproterone
| Article | Year |
|---|---|
Male contraception: expanding reproductive choice.
Topics: Androgens; Condoms; Contraception; Contraceptive Agents; Contraceptive Agents, Male; Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Cyproterone; Desogestrel; Dihydrotestosterone; Epitopes; Estrogens; Hormones; Humans; Levonorgestrel; Male; Nandrolone; Spermatogenesis; Spermatozoa; Testosterone; Time Factors | 2005 |
Combined oral contraceptives: venous thrombosis.
Topics: Androstenes; Contraceptives, Oral, Combined; Cyproterone; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Pulmonary Embolism; Randomized Controlled Trials as Topic; Venous Thrombosis | 2014 |
4 trial(s) available for levonorgestrel and cyproterone
| Article | Year |
|---|---|
Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
Topics: Bone and Bones; Bone Density; Calcium; Climacteric; Cyproterone; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Female; Humans; Levonorgestrel; Middle Aged; Osteoporosis, Postmenopausal; Time Factors; Uterine Hemorrhage | 1992 |
Serum lipids, lipoproteins, and apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxyprogesterone derivatives.
Topics: Androgen Antagonists; Apolipoproteins; Cyproterone; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Humans; Levonorgestrel; Lipid Metabolism; Lipids; Lipoproteins; Medroxyprogesterone; Menopause; Middle Aged; Norgestrel; Norpregnenes | 1991 |
Progestogens: therapeutic and adverse effects in early post-menopausal women.
Topics: Androgen Antagonists; Climacteric; Cyproterone; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Female; Humans; Levonorgestrel; Medroxyprogesterone; Middle Aged; Norgestrel; Severity of Illness Index | 1991 |
Effects of seven low-dose combined contraceptives on vitamin B6 status.
Topics: Adolescent; Adult; Aspartate Aminotransferases; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Desogestrel; Erythrocytes; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norethindrone; Norgestrel; Norpregnenes; Progestins; Pyridoxal Phosphate; Pyridoxine; Time Factors | 1989 |
12 other study(ies) available for levonorgestrel and cyproterone
| Article | Year |
|---|---|
Serum protein binding characteristics of cyproterone acetate, gestodene, levonorgestrel and norethisterone in rat, rabbit, dog, monkey and man.
Topics: Animals; Binding, Competitive; Blood Proteins; Cyproterone; Cyproterone Acetate; Dogs; Female; Humans; Levonorgestrel; Macaca; Norethindrone; Norgestrel; Norpregnenes; Progesterone Congeners; Protein Binding; Rabbits; Radioimmunoassay; Rats | 1990 |
Pharmacokinetics and pharmacodynamics of oral contraceptive steroids: factors influencing steroid metabolism.
Topics: Adolescent; Adult; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Ethinyl Estradiol; Female; Humans; Kinetics; Levonorgestrel; Menstrual Cycle; Norgestrel; Norpregnenes; Sex Hormone-Binding Globulin | 1990 |
Efficacy of low-dose oral contraceptives containing levonorgestrel, gestoden and cyproterone acetate.
Topics: Adolescent; Adult; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Female; Follicle Stimulating Hormone; Gonadal Steroid Hormones; Humans; Levonorgestrel; Luteinizing Hormone; Norgestrel; Ovulation | 1987 |
Time- and dose-dependent alterations of basal and LH-RH-stimulated LH-release during treatment with various hormonal contraceptives.
Topics: Animals; Chlormadinone Acetate; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone; Cyproterone Acetate; Desogestrel; Dose-Response Relationship, Drug; Ethinyl Estradiol; Female; Gonadotropin-Releasing Hormone; Levonorgestrel; Luteinizing Hormone; Norethindrone; Norgestrel; Norpregnenes; Rats | 1984 |
[Therapeutic trend in acne associated with the menstrual cycle].
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Contraceptives, Oral, Combined; Cyproterone; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Menstruation Disturbances; Norgestrel | 1983 |
Plasma levels of levonorgestrel, gestodene, norethisterone and cyproterone acetate on single-dose subcutaneous administration in oily solution in the rat, beagle and rhesus monkey.
Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Combined; Cyproterone; Cyproterone Acetate; Dogs; Female; Half-Life; Injections, Subcutaneous; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Oils; Radioimmunoassay; Rats; Solutions; Species Specificity; Time Factors | 1984 |
Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
Topics: Administration, Oral; Animals; Biological Availability; Cyproterone; Cyproterone Acetate; Dogs; Half-Life; Injections, Intravenous; Injections, Subcutaneous; Kinetics; Levonorgestrel; Macaca mulatta; Norethindrone; Norgestrel; Norpregnenes; Rats; Species Specificity; Stereoisomerism | 1981 |
Risk of venous thromboembolism with cyproterone or levonorgestrel contraceptives.
Topics: Adult; Androgen Antagonists; Body Mass Index; Case-Control Studies; Contraceptives, Oral, Synthetic; Cyproterone; Female; Humans; Levonorgestrel; Risk Factors; Smoking; Venous Thrombosis | 2001 |
Venous thrombosis with cyproterone.
Topics: Androgen Antagonists; Case-Control Studies; Contraceptive Agents, Female; Cyproterone; Female; Humans; Levonorgestrel; Venous Thrombosis | 2002 |
Cyproterone, norethindrone, medroxyprogesterone and levonorgestrel are less potent local human growth hormone and insulin-like growth factor I secretion stimulators than progesterone in human breast cancer explants expressing the estrogen receptor.
Topics: Breast; Breast Neoplasms; Cyproterone; Female; Human Growth Hormone; Humans; Immunohistochemistry; Insulin-Like Growth Factor I; Levonorgestrel; Medroxyprogesterone; Norethindrone; Progesterone; Progesterone Congeners; Receptors, Estrogen | 2002 |
Venous thrombosis with cyproterone (continued).
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Canada; Contraceptives, Oral, Hormonal; Cyproterone; Female; France; Humans; Levonorgestrel; Risk Factors; Venous Thrombosis | 2004 |
Risk of blood clots higher for oral contraceptives with certain progestins.
Topics: Androstenes; Contraceptives, Oral; Cyproterone; Denmark; Desogestrel; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norpregnenes; Progestins; Registries; Risk; Venous Thromboembolism | 2011 |